Researchers Want To Make India Nanotech Drugs Center
This article was originally published in PharmAsia News
A pair of Indian researchers is embarked on a venture to develop nanotechnology drugs, creating a new pharmaceutical industry in India. Kattesh Katti and Raghuraman Kannan, currently researchers at a U.S. university, envision a nanomedicine institution in India to develop the technology. One Indian expert suggests Maharashtra and Tamil Nadu as the prime locations for such an institution. (Click here for more
You may also be interested in...
New report shows average out-of-pocket cost per prescription of $10.67 in 2019 was unchanged from 2018. But while the number of dispensed drugs barely increased, sales jumped more than 5%.
The merger between virtual care companies Teladoc and Livongo will offer individuals a wide range of tech-enabled care during a time when telehealth continues to grow.
Regeneron's antibody cocktail for SARS-Cov-2 is largely in holding mode for now, but the company announced progress on other fronts including for Dupixent in COPD and the NGF inhibitor fasinumab.